Viewing Study NCT00006392



Ignite Creation Date: 2024-05-05 @ 10:23 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00006392
Status: COMPLETED
Last Update Posted: 2015-11-20
First Post: 2000-10-04

Brief Title: S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Sponsor: SWOG Cancer Research Network
Organization: SWOG Cancer Research Network

Study Overview

Official Title: Selenium and Vitamin E Cancer Prevention Trial SELECT for Prostate Cancer
Status: COMPLETED
Status Verified Date: 2015-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SELECT
Brief Summary: RATIONALE Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer It is not yet known which regimen of selenium andor vitamin E may be more effective in preventing prostate cancer

PURPOSE Randomized phase III trial to determine the effectiveness of selenium and vitamin E either alone or together in preventing prostate cancer
Detailed Description: OBJECTIVES

Compare the effect of selenium and vitamin E administered alone vs in combination on the clinical incidence of prostate cancer
Compare the effect of these prevention regimens on the incidence of lung cancer colorectal cancer and all cancers combined in participants on this study
Compare the effect of these prevention regimens on prostate cancer-free survival lung cancer-free survival colorectal cancer-free survival cancer-free survival overall survival and serious cardiovascular events in these participants

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
S0000 OTHER None None
U10CA037429 NIH SWOG httpsreporternihgovquickSearchU10CA037429